Live Breaking News & Updates on Institutional Trading Of Impel Pharmaceuticals

Stay updated with breaking news from Institutional trading of impel pharmaceuticals. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Impel Pharmaceuticals Inc. (NASDAQ:IMPL) Sees Significant Growth in Short Interest

Impel Pharmaceuticals Inc. (NASDAQ:IMPL – Get Rating) was the recipient of a large increase in short interest in April. As of April 30th, there was short interest totalling 424,400 shares, an increase of 8.9% from the April 15th total of 389,700 shares. Approximately 5.5% of the shares of the stock are short sold. Based on […] ....

United States , Impel Pharmaceuticals Company Profile , Impel Pharmaceuticals , Impel Pharmaceuticals Trading Down , Impel Pharmaceuticals Inc , News Ratings For Impel Pharmaceuticals Daily , Geode Capital Management , Institutional Trading Of Impel Pharmaceuticals , Mcdonald Partners , Raymond James Associates , Get Rating , Street Group , Capital Management , Pharmaceuticals Trading Down , Pharmaceuticals Inc , Impel Pharmaceuticals Daily , Nasdaq Impl ,

Impel Pharmaceuticals Inc. (NASDAQ:IMPL) Short Interest Up 8.9% in April

Impel Pharmaceuticals Inc. (NASDAQ:IMPL – Get Rating) was the recipient of a large increase in short interest in April. As of April 30th, there was short interest totalling 424,400 shares, an increase of 8.9% from the April 15th total of 389,700 shares. Based on an average trading volume of 46,600 shares, the days-to-cover ratio is […] ....

United States , Mcdonald Partners , Institutional Trading Of Impel Pharmaceuticals , Tower Research Capital , Impel Pharmaceuticals Inc , Citadel Advisors , Impel Pharmaceuticals , News Ratings For Impel Pharmaceuticals Daily , Impel Pharmaceuticals Price Performance , Raymond James Associates , Get Rating , Street Group , Research Capital , Pharmaceuticals Inc , Impel Pharmaceuticals Daily , Nasdaq Impl ,

Impel Pharmaceuticals (IMPL) Set to Announce Earnings on Friday

Impel Pharmaceuticals (NASDAQ:IMPL – Get Rating) is scheduled to release its earnings data before the market opens on Friday, May 12th. Impel Pharmaceuticals Stock Up 12.6 % NASDAQ IMPL opened at $2.60 on Friday. The company has a market capitalization of $61.75 million, a P/E ratio of -0.57 and a beta of -0.26. Impel Pharmaceuticals […] ....

United States , News Ratings For Impel Pharmaceuticals Daily , Institutional Trading Of Impel Pharmaceuticals , Impel Pharmaceuticals , Goldman Sachs Group Inc , Impel Pharmaceuticals Stock , Earnings History For Impel Pharmaceuticals , Citadel Advisors , Tower Research Capital , Impel Pharmaceuticals Inc , Raymond James Associates , Get Rating , Street Group , Research Capital , Goldman Sachs Group , Sachs Group , Pharmaceuticals Inc , Impel Pharmaceuticals Daily , Nasdaq Impl ,